NCT02247934View on ClinicalTrials.gov

Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Primary Sclerosing Cholangitis
Trial Locations (5)

20814

Evidera, Bethesda

27710

Duke University Medical Center, Durham

33136

University of Miami Miller School of Medicine - Schiff Center for Liver Diseases, Miami

80045

University of Colorado Hospital, Denver Health Medical Center, Aurora

98104

Organ Care Research Swedish Medical Center, Seattle

Sponsors

Lead Sponsor

Gilead Sciences
All Listed Sponsors
lead

Gilead Sciences

INDUSTRY

NCT02247934 - Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC) | Biotech Hunter | Biotech Hunter